Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Bleomycin injections in mice cause skin thickening and hair loss.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Minoxidil can cause a skin reaction called ALEP.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

EK significantly improved wound healing and reduced infection in burn wounds.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

PMEE may help reverse greying hair by boosting melanin production.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Upadacitinib may effectively treat resistant lichen planopilaris.